- Pharmaceutical Technology
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

CHMP recommends AstraZeneca’s Forxiga for approval in EU

If approved, Forxiga will be the first SGLT2 inhibitor indicated for HFrEF. Credit: Raman Oza from Pixabay.